Biographical Information of Directors

Executive Directors

Mr. Li Xiaoming

Mr. Li, obtained a bachelor’s degree in materials science and engineering from East China Institute of Technology (now East China University of Technology) in 2006 and a master’s degree in materials physics and chemistry from Fuzhou University in 2009. He also enrolled in the EMBA program at Cheung Kong Graduate School of Business in October 2024. Mr. Li has been focusing on early-to-mid-stage healthcare and biomedical venture capital investments, with extensive experience in life sciences, biotechnology, AI healthcare, innovative drugs, and novel medical devices, and has successfully invested in over 30 medical projects. He has also been focusing on the intersection of AI and healthcare, with a particular emphasis on research and investment in AI applications across radiology, pathology, multiomics, molecular compound screening, and intelligent rehabilitation. From April 2009 to September 2014, he worked at Guangdong Biolight Meditech Co., Ltd. (Stock Code: 300246), a company listed on the Shenzhen Stock Exchange, with the last position as deputy general manager. He was the director of Tianjin Baolaite Medical Technology Co., Ltd.* (天津寶 萊特醫用科技有限公司) for the period between November 2013 to December 2025; the director of Shenzhen Yikang Tailai Technology Co., Ltd.* (深圳市益康泰來科技有限公 司) for the period between December 2015 to July 2021; and the director of Shenzhen Jiahua Hospital Management Co., Ltd.*(深圳市嘉華醫院管理有限公司) for the period betApril 2017 to December 2022. He has been the general manager and chairman of Shenzhen Yanghe Biomedicine Industry Investment Co., Ltd. (深圳市陽和生物醫藥產業投資有限公 司) since October 2014; the director of Guangzhou Liangyi Information Technology Co., Ltd* (廣州良醫信息科技有限公司) since July 2019 and the director of Guangzhou OO Medical Technology Co., Ltd.*(廣州歐歐醫療科技有限責任公司) since August 2019. Mr. Li was appointed as a non-independent director of Nanjing Vishee Medical Technology Co., Ltd. (Shanghai Stock Exchange Stock Code: 688580) from November 2021 to November 2024; and has been appointed as a non-independent director of Guangdong Biolight Meditech Co., Ltd. (Shenzhen Stock Exchange Stock Code: 300246) since May 2020.ween

Mr. Lee Chi Ho

Mr. Lee Chi Ho, is a fellow member of the Association of Chartered Certified Accountants and has over 20 years of experience in the finance, auditing and accounting sectors. He obtained his Bachelor of Arts in Accountancy from The Hong Kong Polytechnic University in 2004. Mr. Lee has been serving as the chief financial officer for the Company since November 2023 and for TOMO Holdings Limited (Stock code: 6928), a company listed on the Main Board of the Stock Exchange, since April 2023. Mr. Lee has been appointed as an independent non-executive director for China Environmental Resources Group Limited (Stock Code: 1130), a company listed on the Main Board of the Stock Exchange, since December 2023. He previously worked as chief financial officer for various companies in Hong Kong and the People’s Republic of China from June 2014 to April 2023. From August 2004 to December 2013, Mr. Lee was employed at Deloitte Touche Tohmatsu in Hong Kong and its affiliates operating in Shenzhen and Shanghai, with the last position as Audit Manager.

Independent Non-Executive Directors

Ms. Li Qian

Ms. Li Qian, has over 14 years of experience in finance, auditing and accounting. She obtained her bachelor’s degree in finance management from Guangdong University of Finance in June 2009. Ms. Li is currently a head of finance department of Shenzhen Yulin Culture and Sports Technology Co., Ltd.* (深圳羽林文化體育科技有限公司). For the period between May 2023 and August 2024, Ms. Li worked as a senior auditor at Pengsheng Certified Public Accountants (Special General Partnership)* (鵬盛會計師事務所（特殊普通合伙）). She worked in China United Network Communications Group Co., Ltd Heyuan Branch* (中國聯 合網絡通信有限公司河源市分公司) for the period between September 2010 to April 2023 with the last position as deputy manager of marketing department.

Mr. Lee Chan Wah

Mr. Lee, obtained his bachelor degree of Business Administration from the Hong Kong Baptist University in 1991. He has been a member of the Hong Kong Institute of Certified Public Accountants and the Association of Chartered Certified Accountants since 1996. He has over 20 years of experience in the field of auditing, accounting and finance. From 14 February 2022 to 10 July 2023, Mr. Lee served as an executive director of Zijing International Financial Holdings Limited, a company listed on GEM of the Stock Exchange (stock code: 8340). He has been an independent non-executive directors of Shanghai International Shanghai Growth Investment Limited, a company listed on the Main Board of the Stock Exchange (stock code: 770) since 30 January 2026.